Wambolt & Associates, LLC Merck & Co., Inc. Transaction History

Wambolt & Associates, LLC

$342 Million
Q2 2024

A detailed history of Wambolt & Associates, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Wambolt & Associates, LLC holds 3,672 shares of MRK stock, worth $373,258. This represents 0.13% of its overall portfolio holdings.

Number of Shares

3,672

Previous 3,862 4.92%

Holding current value

$373,258

Previous $509,000 10.81%

% of portfolio

0.13%

Previous 0.15%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$123.8 - $132.96 $23,522 - $25,262	-190 Reduced 4.92%	3,672 $454,000
Q1 2024 Apr 30, 2024	SELL	$113.24 - $131.95 $166,689 - $194,230	-1,472 Reduced 27.6%	3,862 $509,000
Q4 2023 Feb 07, 2024	SELL	$100.18 - $109.02 $25,846 - $28,127	-258 Reduced 4.61%	5,334 $581,000
Q3 2023 Nov 06, 2023	BUY	$102.95 - $114.33 $74,124 - $82,317	720 Added 14.78%	5,592 $575,000
Q2 2023 Aug 02, 2023	BUY	$108.61 - $118.38 $53,436 - $58,242	492 Added 11.23%	4,872 $562,000
Q1 2023 May 05, 2023	SELL	$102.94 - $114.86 $2,779 - $3,101	-27 Reduced 0.61%	4,380 $465,000
Q4 2022 Jan 31, 2023	SELL	$87.44 - $112.11 $8,044 - $10,314	-92 Reduced 2.04%	4,407 $488,000
Q3 2022 Oct 18, 2022	SELL	$84.53 - $94.96 $3,803 - $4,273	-45 Reduced 0.99%	4,499 $387,000
Q2 2022 Aug 01, 2022	SELL	$83.49 - $94.64 $918 - $1,041	-11 Reduced 0.24%	4,544 $414,000
Q1 2022 May 10, 2022	BUY	$73.51 - $82.4 $5,366 - $6,015	73 Added 1.63%	4,555 $380,000
Q4 2021 Feb 08, 2022	BUY	$72.28 - $90.54 $72 - $90	1 Added 0.02%	4,482 $344,000
Q3 2021 Oct 20, 2021	SELL	$71.68 - $78.83 $15,841 - $17,421	-221 Reduced 4.7%	4,481 $365,000
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $59,552 - $65,871	847 Added 21.97%	4,702 $367,000
Q1 2021 Apr 19, 2021	SELL	$68.86 - $81.11 $45,516 - $53,613	-661 Reduced 14.64%	3,855 $297,000
Q4 2020 Jan 19, 2021	BUY	$71.77 - $79.65 $574 - $637	8 Added 0.18%	4,516 $369,000
Q3 2020 Nov 04, 2020	SELL	$73.18 - $82.95 $5,488 - $6,221	-75 Reduced 1.64%	4,508 $374,000
Q2 2020 Jul 23, 2020	BUY	$70.42 - $80.13 $47,603 - $54,167	676 Added 17.3%	4,583 $354,000
Q1 2020 May 11, 2020	BUY	$63.36 - $87.82 $48,597 - $67,357	767 Added 24.43%	3,907 $301,000
Q4 2019 Feb 10, 2020	BUY	$77.58 - $87.54 $243,601 - $274,875	3,140 New	3,140 $286,000

Others Institutions Holding MRK

# of Institutions

3,807

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $258B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wambolt & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wambolt & Associates, LLC with notifications on news.

Account

Wambolt & Associates, LLC Merck & Co., Inc. Transaction History